The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing? [electronic resource]
- Annals of oncology : official journal of the European Society for Medical Oncology May 2002
- 653-68 p. digital
Publication Type: Journal Article; Review
0923-7534
10.1093/annonc/mdf142 doi
Antineoplastic Combined Chemotherapy Protocols--therapeutic use Female Humans Male Neoplasms--diagnosis Octreotide--adverse effects Peptides, Cyclic--adverse effects Randomized Controlled Trials as Topic Sensitivity and Specificity Somatostatin--adverse effects Survival Analysis Treatment Outcome